Daily biotech dealflow + market tape in 5 minutes — for VC, BD&L, and public biotech investors.
Jan 5, 2026
Servier taps Insilico’s AI platform, Novo prices the Wegovy pill, and Sanofi’s Tzield gets priority review.
Dec 30, 2025
Ultragenyx/Mereo stumble in rare bone disease, a small raise prints, and Denali lands an NEJM publication.
Dec 29, 2025
CMS tees up a new GLP-1 payment model, Biohaven eats a Phase 2 miss, and J&J trims a $1.25B deal.
